ESR1 and breast neoplasm: Importantly, our data show that the enrichment of both ER-regulated gene signatures was observed in the cell populations of metastatic PDX tumors, as well as in the more aggressive ER+ breast tumors of patients, despite Signature 1 not correlating with invasive potential, which further suggests a role for heterogenic ER activity in metastasis.